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instrument has ﬁ ve functional scales (physical, role, cognitive, emotional, and social), 
three symptom scales (fatigue, pain, and emesis), and a global health/quality of life 
scale. The remaining single items assess dyspnoea, appetite loss, sleep disturbance,
constipation, and diarrhoea. The analyses focused on intraclass correlation coefﬁ cients 
(ICCs), comparing the ICC 95% lower conﬁ dence interval with a critical value of 
0.70. RESULTS: Subjects who did not complete the second assessments within 72 
hours or who had score differences on the scales or items exceeding two standard
deviations were excluded from the per protocol analyses. The sample sizes used in the
per protocol analyses ranged from 112 to 115 subjects. The ICCs for the 9 multi-item
scales were all above 0.69, ranging from 0.698 to 0.926 (ICC 95% lower CI range:
0.608 to 0.901). All of the scales were signiﬁ cantly different from our threshold reli-
ability of 0.70, with the exception of the cognitive functioning scale. The ICCs for the
6 single items ranged from 0.782 to 0.908 (ICC 95% lower CI range: 0.714 to 0.876) 
and all were statistically different from 0.70. The evidence supports the stability of 
the scores obtained on the IVR version of the QLQ-C30 upon repeated measurement. 
CONCLUSIONS: The equivalence of the IVR and paper versions of the QLQ-C30
has been demonstrated elsewhere. This analysis provides additional evidence of the
test-retest reliability of the IVR version of the QLQ-C30.
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OBJECTIVES: Research indicates 18% to 96% of cancer patients experience fatigue
due to cancer or its treatment. Only one claim for “cancer-related fatigue” (CF) has
been granted by the US Regulatory Authorities. To date, the deﬁ nition or diagnosis
of CF remains a subject for debate within the clinical community. Although several
self-completed CF-speciﬁ c instruments are available, the lack of an accepted concep-
tual framework articulating those concepts important to patients has hampered 
research in this ﬁ eld. Developing a preliminary conceptual framework able to underpin
patients’ experience of CF is central to gather meaningful data. Qualitative articles 
with verbatim patient quotes were reviewed and synthesized to begin a large effort 
to develop such a framework. METHODS: A systematic search identiﬁ ed 95 articles 
published between 1996 and 2007 containing patient quotes. Search terms included
fatigue, tiredness, lassitude, weakness, or asthenia. Two researchers independently 
reviewed articles; 645 quotes were extracted and systematically analyzed to identify 
concepts and language used to describe patients’ CF experiences. RESULTS: CF is 
more intense than pre-diagnosis or treatment tiredness. Terms such as “overwhelm-
ing,” “unusual,” and “all-encompassing” were used to describe CF. Quotes referring
to “tiredness” were often associated with adverbs (very, extremely) or patients’ idi-
omatic phrases intensifying “tiredness” (e.g., “dead-tired”, “sick-tired”) to distinguish 
tiredness due to CF. Metaphors depicted the severity and debility associated with CF. 
CONCLUSIONS: Findings suggest that extant CF assessments fail to capture the 
unique experience of CF as described by patients. Publication bias and lack of primary
data from which quotes were drawn are study limitations. Rigorous qualitative 
research with patients with different types and stages of cancer is needed to concisely
and comprehensively describe the experience of CF and its impact.
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OBJECTIVES: To estimate the impact of performance status (ECOG), age, concomi-
tant conditions, length of diagnosis, exposure to chemotherapy treatment and care-
giver need on health related quality of life (HRQoL) in 800 adult female breast cancer
patients in the USA and 5 European countries (France, Germany, Italy, Spain and UK). 
METHODS: Data were drawn from the Adelphi Breast Cancer Disease Speciﬁ c Pro-
gramme (DSP), a cross-sectional study of consulting patients, undertaken in 2007. 
Physicians collected data on the next 7 patients presenting with breast cancer during
the study period. Patients were asked to report on their HRQoL (FACT-B). OLS 
regressions were performed using STATA. Diagnostic tests were performed (joint sig-
niﬁ cance, misspeciﬁ cation and multicolinearity) and White standard errors were
applied. RESULTS: Eight hundred (Europe, 686; USA, 114) patient records were 
analysed. FACT-B scores were signiﬁ cantly impacted in line with worsening ECOG
performance status (Grade 1: 7.44, overall; 5.94, USA; 13.48, Europe; all p 
0.001: Grade 2: 14.92, overall; 13.45, USA; 19.39, Europe; all p  0.001: Grade
3: 22.04, overall; 20.87, USA; 21.94, Europe; all p  0.001, except USA, p  0.05).
No Grade 4 patients were present in the sample. FACT-B scores were lower overall 
and in Europe, in patients currently receiving chemotherapy (-9.13, overall; 9.78,
Europe; all p  0.001), those with a caregiver (5.64, overall; 7.05, Europe; all p 
0.001). Longer diagnosis (0.82, P  0.05) and presence of mental health related 
concomitant conditions (7.25, P  0.05) were signiﬁ cant in US patients only. Age and
heart related concomitant conditions were not signiﬁ cant. Models showed overall
robustness to the diagnostic tests performed. CONCLUSIONS: A signiﬁ cant associa-
tion was seen between the patient-reported FACT-B scores and the physician-reported 
ECOG performance status. The impact of the various factors identiﬁ ed, including 
chemotherapy use, mental health related concomitant conditions and time since diag-
nosis, can provide useful indicators to be taken into account in the management of 
breast cancer patients.
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OBJECTIVES: The objective of this analysis was to develop a new analytic methodol-
ogy to identify a clinically relevant cut-off point in the EORTC QLQ-C30 ordinal
pain score by comparing patient and clinician reporting for the same symptom. Ability 
to translate between clinician and patient reported symptoms will be useful in planned 
future analyses. METHODS: Closed European Organisation for Research and Treat-
ment of Cancer Randomized Controlled Trials, where the symptom pain was scored
at baseline by the patient (EORTC QLQ-C30) and the clinician [Common Toxicity
Criteria (CTC)], were pooled and analysed to test the optimal cut-off point. The CTC 
was dichotomized as 0,1,2 vs. 3,4; deﬁ ned as a clinical relevant cut-off point for clini-
cal practice. Percent agreement with various dichotomizations of the QLQ-C30 pain 
scale was calculated, and McNemar’s test applied. Veriﬁ cation of the accuracy and 
generalizibility of the ﬁ ndings was evaluated with a validation set and by applying the 
same cut-off point on another symptom, i.e. fatigue. RESULTS: Data were available 
for pain [number of trials (t)  8, number of patients (n)  1214] and fatigue [t  5, 
n  1237]. Model and validation set were obtained by splitting the dataset in half.
Percentage agreement and p values for McNemar tests, between patient and clinician 
dichotomized scores using different cut-off points for the QLQ-scale, were: median 
(2.19 vs. 2.19, 64%, p  .01), quartile (vs. 3.0, 81%, p  0.55), decile (4.0 vs. 
4.0, 85%, p  0.01). The quartile split reﬂ ects best the dichotomized CTC score. This 
was conﬁ rmed in the validation set (quartile cut-off point: 82%, p  0.86). However, 
when the quartile cut-off was applied to the QLQ-C30 fatigue scale, a signiﬁ cant dif-
ference (p  .01) between patient and clinician results was found. CONCLUSIONS:
Our results indicate that a quartile split of the QLQ-C30 pain score is optimal. 
However, a single cut-point may not generalize to other QLQ-C30 symptoms;
symptom-speciﬁ c cut-points may be required.
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OBJECTIVES: To examine what information that parents of children with life-limiting 
conditions want from physicians and whether the provision of this information pro-
motes parents’ trust in physicians. METHODS: We conducted telephone surveys from
November 2007 through April 2008 with a random sample of 266 parents whose
children had life-limiting conditions and enrolled in Florida’s State Title V Children 
with Special Health Care Needs Program. Parents were asked if they wanted informa-
tion about the following: the child’s quality of life, pain relief, prognosis, incorporating
spiritual beliefs into the treatment plan, how treatments might change the child’s
appearance, and clinical examination/laboratory results. We used the Wake Forest
Physician Trust Scale to measure parent’s trust in physicians. We tested the relation-
ships between parent’s age, race/ethnicity, education, marital status, and parent-
reported children’s health status and desired information. We also tested whether
provision of this desired information was associated with greater trust in physicians.
RESULTS: Most parents wanted information on their children’s quality of life (95%), 
followed by the prognosis (88%) and pain relief (84%). Forty-nine percent of the 
parents desired advice from family/friends. Compared to parents with a high school 
education or higher, parents with less than a high school education showed a greater 
desire for information on pain relief and spiritual belief (p  0.05). Compared to White 
non-Hispanic parents, Hispanic and Black non-Hispanic parents showed a greater
desire for information on the child’s prognosis, incorporating spiritual beliefs into the
treatment plan, and the impact of the treatment on the child’s appearance (p  0.05). 
Providing information on children’s quality of life and pain relief was associated with 
greater trust in physicians after adjusting for parental characteristics (p  0.05). 
CONCLUSIONS: Parents wanted information on their children’s quality of life more 
so than any other information category. Providing this information along with infor-
mation about pain relief increased the families’ trust in the physicians.
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TREATMENT DECISION MAKING FOR THEIR CHILDREN
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OBJECTIVES: To examine the association between characteristics of parents whose 
children are diagnosed with life-limiting conditions, trust in physicians, and problems
in the shared decision making process. METHODS: This study using data collected 
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from parents whose children have life-limiting conditions and enrolled in Florida’s 
State Title V Program. Telephone surveys were conducted using 266 random parents 
between November 2007 and April 2008. The Wake Forest Physician Trust Scale was
used to measure parents’ trust in physicians. The Decisional Conﬂ ict Scale (DCS) was 
used to measure conﬂ icts in decision making, e.g., uncertainty and uninformed and 
ineffective choices. The total score of DCS to represent the magnitude of decisional
conﬂ icts. We conducted multivariate analyses to test whether parent’s age, race, educa-
tion, personality traits, and parent-report of children’s health status were associated
with physician trust and decisional conﬂ icts. We tested whether greater trust in physi-
cians was associated with less decisional conﬂ icts after controlling for parental char-
acteristics. RESULTS: Parents with less than a high school education reported less 
trust in physicians as compared to parents with above a high school education (p 
0.05). Hispanic parents were less likely to trust in their physicians and had more
decisional conﬂ icts than White parents (p  0.05). Parents with lower level of consci-
entiousness, emotional stability and openness to experiences were associated with less
trust in physicians and more decisional conﬂ icts as compared to their counterparts
(p  0.05). Parents’ age and children’s health status were not signiﬁ cant factors of 
physician trust and decisional conﬂ icts (p  0.05). Parents’ trust in physicians were 
signiﬁ cantly related to conﬂ icts in the decision-making process (p  0.05). CONCLU-
SIONS: For children with life-limiting conditions, parents who were minority, less 
educated, and with negative personality traits reported less trust in physicians and
more conﬂ icts in the decision making process. Trust plays a signiﬁ cant role in parents’ 
treatment decision making beyond the inﬂ uence of parents’ characteristics.
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OBJECTIVES: The aim of this study was to identify the oncologic patients’ (non
hodgkin lymphoma, breast and colorectal cancer) satisfaction grade with the medical 
care in a tertiary referral center at the Social Security Mexican Institute (IMSS). 
METHODS: A cross-sectional and descriptive study was performed within a tertiary
referral center in Guadalajara City, Mexico. Were included oncologic patients with
non hodgkin lymphoma, breast and colorectal cancer attended as outpatients since
July to August 2008. Was performed an interview with EORTC IN-PATSAT32 in 
Spanish version, this instrument contents 32 items with Likert-like scale answers (1–5) 
to evaluate follow assumptions: medical care, nurse care, other personal care, waiting
time, access facilities to hospital, information exchange, cleaning, comfort and general 
satisfaction (scale 1 to 100). Internal consistency was evaluated through Cronbach’s
alpha test. This questionnaire was previously validated to Mexico. ANOVA was used 
to identify differences between clinical stages and each disease. Statistical analysis was
realized in SPSS 13.0. RESULTS: This study included 157 patients with breast cancer,
30 colorectal cancers and 14 non hodgkin lymphoma. Mean of satisfaction inter-item
was 75 o 18 (20–100), in patients with breast cancer, satisfaction level was 75 o 18, 
non-hodgkin lymphoma 85 o 13 and colorectal cancer 75 o 19, without statistical
difference between diseases (p  0.14). The items with lowest score were cleaning (52
o 34), and other personal care (68 o 27). The highest score were nurse care (86 o 21), 
speciﬁ cally non hodgkin lymphoma group (94 o 14). CONCLUSIONS: The oncologic 
patients’ (non hodgkin lymphoma, breast and colorectal cancer) group was satisﬁ ed 
with the medical care, particularly with the nurses group.
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OBJECTIVES: According to the National Cancer Institute (INCA 2008), breast cancer
(BC) is the malignant neoplasia which more affects Brazilian women (estimated 49,400 
cases, with a crude incidence rate of 50.71 cases per 100 thousand women). Moreover, 
Health Ministry data shows that the mortality rate of the disease is increasing, in
contrast developed countries, such as US (New England Journal of Medicine, 2005).
This mortality may be partially explained by the advanced stages of the disease at
diagnosis (III and IV), which represent 50% of new identiﬁ ed cases in Brazil (INCA
2005). This may be a result of population low awareness of BC and the importance
of early detection. Thus, the objective of this study is to assess women’s knowledge 
of this neoplasia, their perception of its risks and methods of diagnosis. METHODS:
Quantitative study performed through personal and individual interviews. A represen-
tative sample of the population (N  552) was used, composed by women between
30 and 60 year-old living in 4 capitals of Brazil (Rio de Janeiro, Sao Paulo, Porto
Alegre and Salvador). A 20-question structured questionnaire was applied. RESULTS:
Ninety percent of interviewed women understand cancer as a disease that brings health 
risks, highlighting breast (79%) as the most threatening cancer. The majority pointed
out self breast examination (82%) as the best diagnostic method for BC early detec-
tion, followed by mammography (35%). The main information sources of this neo-
plasia, which were spontaneously mentioned were: television shows (80%), hospitals 
(28%), and newspapers (22%). CONCLUSIONS: 79% of all Brazilian women are
aware of the threat BC means to their health, but only some of them see mammogra-
phy (35%) as a method that most importantly can increase the chance of an early
diagnosis. These results will support informative continuous campaigns about the
importance of early detection aiming to give population a greater chance of cure.
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OBJECTIVES: We explored oncologists’ attitudes toward the costs and cost effective-
ness of cancer drugs and their views on various reimbursement policies in the United 
States. METHODS: We surveyed 1379 oncologists based in the United States, selected 
from the American Society of Clinical Oncology (ASCO) membership list. Self-admin-
istered surveys were disseminated by mail between January and August 2008. The 
survey covered the degree to which oncologists believe that treatment costs and 
patients’ out-of-pocket spending inﬂ uence their prescribing behavior. We also asked 
whether the oncologists discuss costs with patients and about the potential use of 
comparative effectiveness and cost effectiveness information. RESULTS: A total of 
787 oncologists responded (response rate 57%). Sixty-seven percent of respondents 
stated that every U.S. patient should have access to effective cancer treatment regard-
less of cost; however, 56% stated that costs inﬂ uenced their decisions about which 
cancer treatments to recommend, and 84% agreed that patient out-of-pocket costs 
inﬂ uenced decisions. Only 42% said they always or frequently discussed cost issues 
with patients. A majority (80%) supported more use of cost effectiveness data in
coverage and payment decisions; only 41% felt well prepared to interpret and use
such information. Respondents leaned toward more government intervention: 57% 
agreed that government price controls for cancer drugs for Medicare were needed; 
79% favored more government research on the comparative effectiveness of cancer 
drugs. After adjusting for other factors, older MDs were more likely to be inﬂ uenced 
by cost and more likely to discuss costs with patients. CONCLUSIONS: Oncologists 
believe that costs inﬂ uence their prescribing, yet relatively few report discussing costs 
frequently with patients. The results highlight the need to educate physicians about 
treatment costs and cost effectiveness and to develop better communication strategies.
They also support research on the comparative effectiveness and cost-effectiveness of 
cancer therapies.
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OBJECTIVES: Cancer and muscular-skeletal diseases are embraced in the group of 
diseases requesting a high number of the health care resources, imposing a substantial 
economic burden to patient, health-social insurance and to society in Slovakia. The 
objective of the study was to estimate the number of productivity lost days and cal-
culate the indirect costs associated with the consumption of the health-social insurance 
system. METHODS: With the use of a national database of patients we developed a
retrospective analysis with the identiﬁ cation of the number of productivity lost days 
due to cancer and muscular-skeletal disorders during the period of the year 2007. By 
the comparison-analysis we analyzed the differences between the longest and the
shortest period of productivity lost focusing on the cancer and muscular-skeletal and
we calculated the health-social insurance costs. RESULTS: Cancer shows the average 
number of productivity lost in males 104.2 and 74.3 in females, the longest period of 
days of productivity lost represent 151.4 days in males age 60 and more and 119.7
days in females age 55–59. Muscular-skeletal diseases showed these results: in average 
41.2 days in males and 50.3 days in females. The longest period of days of productivity
lost, is 64.4 days in males age 55–59, and 76.9 days in females age 60. One day of 
productivity lost costs the health-social insurance system in average €140.78 per 
patient, in this case, days of lost productivity due to cancer represent the average costs
of health insurance €25.129,23 and due to the muscular-skeletal €12.881,37; in both 
gender together. This number represents indirect costs. CONCLUSIONS: This retro-
spective analysis highlighted the importance to pay attention to indirect cost during 
the overall management of decision-making process for the cancer and muscular-
skeletal diseases due to their high supplies of health resources.
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OBJECTIVES: Little information is available about physician visit and referral
patterns among patients diagnosed with Stage IV PCa. The objective of this study 
